Dr. Harrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-8441Fax+1 414-805-6980
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematopathology, 2008 - 2009- Medical College of Wisconsin Affiliated HospitalsResidency, Pathology-Anatomic and Clinical, 2004 - 2008
- Medical College of WisconsinClass of 2004
Certifications & Licensure
WI State Medical License 2005 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.Sameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C Michaelis, Karen-Sue Carlson
Leukemia. 2025-02-15 - 4 citationsA phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin
Haematologica. 2024-09-01 - Primary Bone Lymphoma Masquerading as Multiple Myeloma: Challenges in the Diagnostic Workup of Severe Hypercalcemia.Elise Kahn, Laila Nomani, Alexandra M Harrington, Nisar Asmi
Cureus. 2024-01-01
Press Mentions
- Daratumumab in Primary Effusion LymphomaAugust 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
